129 related articles for article (PubMed ID: 32828381)
1. Introduction: Cervical Cancer.
Klopp AH
Semin Radiat Oncol; 2020 Oct; 30(4):263-264. PubMed ID: 32828381
[No Abstract] [Full Text] [Related]
2. Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma.
Cho O; Chun M; Oh YT; Noh OK; Chang SJ; Ryu HS; Lee EJ
Tumour Biol; 2017 Oct; 39(10):1010428317733144. PubMed ID: 29022484
[TBL] [Abstract][Full Text] [Related]
3. Impact on treatment time of MRI-based brachytherapy in two implants (4 doses) compared with CT-based brachytherapy in five implants for cervical cancer.
Small C; Harmon G; Weaver J; Vivirito V; Durazo-Arvizu R; Small W; Harkenrider MM
Brachytherapy; 2019; 18(2):141-145. PubMed ID: 30497938
[TBL] [Abstract][Full Text] [Related]
4. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy.
Haie-Meder C; Chargari C; Rey A; Dumas I; Morice P; Magné N
Radiother Oncol; 2010 Aug; 96(2):161-5. PubMed ID: 20655120
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
Hirata K; Kodaira T; Tomita N; Ohshima Y; Ito J; Tachibana H; Nakanishi T; Fuwa N
Jpn J Clin Oncol; 2014 Jun; 44(6):556-63. PubMed ID: 24755546
[TBL] [Abstract][Full Text] [Related]
7. Intra-fraction uncertainties of MRI guided brachytherapy in patients with cervical cancer.
Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Westerveld H; Jürgenliemk-Schulz IM
Radiother Oncol; 2014 Aug; 112(2):217-20. PubMed ID: 25216574
[TBL] [Abstract][Full Text] [Related]
8. National survey of intracavitary brachytherapy for intact uterine cervical cancer in Japan.
Toita T; Ohno T; Ikushima H; Nishimura T; Uno T; Ogawa K; Onishi H; Dokiya T; Itami J;
J Radiat Res; 2018 Jul; 59(4):469-476. PubMed ID: 29986113
[TBL] [Abstract][Full Text] [Related]
9. Tumor shrinkage before intracavitary brachytherapy for cancer of the cervix: radiotherapy alone versus concurrent chemoradiotherapy.
Kim RY; Spencer SA
Cancer J; 2000; 6(6):377-80. PubMed ID: 11131487
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
[TBL] [Abstract][Full Text] [Related]
11. Fractionated high-dose-rate brachytherapy in the management of uterine cervical cancer.
Park HC; Suh CO; Kim GE
Yonsei Med J; 2002 Dec; 43(6):737-48. PubMed ID: 12497657
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy-based radiotherapy is associated with improved survival for newly diagnosed metastatic cervical cancer.
Ding L; Bi Z; Pan Z; Yu X; Zhao X; Bai S; Yao H; Liu Y
Brachytherapy; 2021; 20(2):361-367. PubMed ID: 33317966
[TBL] [Abstract][Full Text] [Related]
13. FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
Huertas A; Oldrini S; Nesseler JP; Courrech F; Rétif P; Charra-Brunaud C; Peiffert D
Cancer Radiother; 2017 Apr; 21(2):155-163. PubMed ID: 28233697
[TBL] [Abstract][Full Text] [Related]
14. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups.
Macchia G; Cerrotta A; Deodato F; Pappalardi B; Santoni R; Campitelli M; Scambia G; Valentini V; Aristei C; Ferrandina G
Crit Rev Oncol Hematol; 2020 May; 149():102925. PubMed ID: 32200268
[TBL] [Abstract][Full Text] [Related]
16. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
[TBL] [Abstract][Full Text] [Related]
17. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
[TBL] [Abstract][Full Text] [Related]
18. High-precision MRI-guided adaptive brachytherapy for cervical carcinoma.
Conibear J; Lowe G; Hoskin PJ
Int J Hyperthermia; 2012; 28(6):501-8. PubMed ID: 22834543
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic significance of magnetic resonance imaging in patients with cervical cancer after brachytherapy: a meta-analysis.
Zhang J; Tian W; Bu X; Wang X; Tian F; Wu L
Acta Radiol; 2019 May; 60(5):670-676. PubMed ID: 30149749
[TBL] [Abstract][Full Text] [Related]
20. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
